Skip to main content

Find Clinical Trials

Clinical trial condition

AML

Explore clinical trials studying AML. Study availability and eligibility vary by location and protocol.

139 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

AML trial results

Completed

Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT

NCT01012492

Conditions: ALL, AML, Anemia, +18 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function

NCT00652626

Conditions: AML, Blood Protein Disorders, Cardiovascular Diseases, +28 more
Locations: Sutter East Bay Hospitals Berkeley, California, United States

Palm Springs Research Institute Hialeah, Florida, United States

MCG Cancer Center Augusta, Georgia, United States

Joliet Oncology-Hematology Associates, Ltd. Joliet, Illinois, United States

View Trial Details

Completed

Ascorbic Acid Levels in MDS, AML, and CMML Patients

NCT03526666

Conditions: AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +17 more
Locations: Cancer and Hematology Centers of Western Michigan Grand Rapids, Michigan, United States

Metro Health - University of Michigan Health Wyoming, Michigan, United States

View Trial Details

Completed

Sirolimus in Combination With MEC in High Risk Myeloid Leukemias

NCT00780104

Conditions: AML, CML, Hematologic Diseases, +6 more
Locations: University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML

NCT02662647

Conditions: AML
Locations: Navy General Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

NCT01319864

Conditions: ALL, AML, Acute Leukemia of Ambiguous Lineage, +20 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

The Children's Hospital of Denver Denver, Colorado, United States

Children's Healthcare of Atlanta/Emory University Atlanta, Georgia, United States

Johns Hopkins Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)

NCT00422591

Conditions: AML, Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)

NCT00542971

Conditions: AML, Acute Myeloid Leukemia, Hematologic Diseases, +7 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)

NCT01994837

Conditions: AML, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, +7 more
Locations: Not specified

View Trial Details

Completed

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

NCT00539695

Conditions: ALL, AML, Acute Lymphoblastic Leukemia, +31 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details